Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthequity (HQY) Non-Current Assets (2016 - 2025)

Historic Non-Current Assets for Healthequity (HQY) over the last 12 years, with Q4 2025 value amounting to $2.9 billion.

  • Healthequity's Non-Current Assets fell 313.21% to $2.9 billion in Q4 2025 from the same period last year, while for Oct 2025 it was $11.7 billion, marking a year-over-year increase of 242.24%. This contributed to the annual value of $3.0 billion for FY2025, which is 1398.3% up from last year.
  • According to the latest figures from Q4 2025, Healthequity's Non-Current Assets is $2.9 billion, which was down 313.21% from $2.9 billion recorded in Q3 2025.
  • In the past 5 years, Healthequity's Non-Current Assets registered a high of $3.0 billion during Q3 2024, and its lowest value of $2.3 billion during Q1 2021.
  • Moreover, its 5-year median value for Non-Current Assets was $2.7 billion (2022), whereas its average is $2.7 billion.
  • In the last 5 years, Healthequity's Non-Current Assets skyrocketed by 2246.59% in 2022 and then plummeted by 439.49% in 2023.
  • Over the past 5 years, Healthequity's Non-Current Assets (Quarter) stood at $2.3 billion in 2021, then grew by 17.0% to $2.7 billion in 2022, then dropped by 4.15% to $2.6 billion in 2023, then increased by 14.28% to $3.0 billion in 2024, then decreased by 3.13% to $2.9 billion in 2025.
  • Its Non-Current Assets stands at $2.9 billion for Q4 2025, versus $2.9 billion for Q3 2025 and $2.9 billion for Q2 2025.